Exdensur 100 mg/mL
depemokimab · INJECTION, SOLUTION · GlaxoSmithKline LLC
No Recall History
Plain English
Exdensur is a injection, solution containing depemokimab at 100 mg/mL, taken subcutaneous. Manufactured by GlaxoSmithKline LLC.
Key Facts
- Brand Name
- Exdensur
- Generic Name
- depemokimab
- NDC Code (Product)
0173-0927- Manufacturer
- GlaxoSmithKline LLC
- Strength
- 100 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761458
- Marketing Start
- 12/16/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is Exdensur used for?
Exdensur contains depemokimab. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Exdensur a controlled substance?
Exdensur is not classified as a controlled substance by the DEA.
What is the generic name for Exdensur?
The generic name for Exdensur is depemokimab. There are no other listed brand versions of depemokimab.
What is the NDC code for Exdensur 100 mg/mL?
The NDC (National Drug Code) for Exdensur 100 mg/mL is 0173-0927, listed by GlaxoSmithKline LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)